#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alveolar rhabdomyosarcoma Hairy cell leukaemia Cervix carcinoma Erdheim-Chester disease Glioblastoma Obliterative bronchiolitis Congenital hypotransferrinaemia Encephalitis autoimmune Vernal keratoconjunctivitis Hyperadrenocorticism Astrocytoma Waldenstrom's macroglobulinaemia refractory Immune-mediated enterocolitis Cardiac failure acute Cholestatic pruritus More trials…

    Learn about Rare Diseases

    CADASIL – Trials in Disease Pleomorphic leiomyosarcoma – Basic Information Cystic fibrosis lung – Trials in Disease Krabbe’s disease – Trials in Disease VEXAS syndrome – Basic Information Ocular melanoma Leiomyosarcoma Nephrotic syndrome – Trials in Disease Cytokine release syndrome – Life with Disease Lymphangioma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Festuca Elatior Pollen Extract SECRETIN SYNTHETIC HUMAN Varnimcabtagene Autoleucel Brimonidine Tartrate SONLICROMANOL HYDROCHLORIDE Troriluzole Lenalidomide Sacubitril Valsartan GSKVX000000030918 Eplerenone Ecoo18A Ttx-030 NALOXEGOL Albiglutide Petosemtamab NADOFARAGENE FIRADENOVEC L-Lysine Acetate MRNA-1345 Prednisone Promazine Hydrochloride More therapies…

    Learn about Your Condition

    Obstructive pancreatitis Muscle strain Craniotomy Acoustic neuroma Hypertension Lower limb fracture Hysterectomy Staphylococcal bacteraemia Complex regional pain syndrome Ependymoma malignant Cardiac failure Colorectal cancer stage III Shock Follicular lymphoma stage II Partial lipodystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study of AZD9550 and AZD6234 combination for weight loss in people with obesity or overweight with health complications

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • AZD6234
    • Azd9550
    • Calcium
    Germany

  • Study on Maintaining Weight Loss in Teens with Obesity Using Semaglutide

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Belgium Denmark France Germany Greece Italy +2

  • Study on Petrelintide for Weight Loss in Overweight or Obese Patients with Related Health Issues

    Not recruiting

    2 1
    Investigated Drugs:
    • Petrelintide
    Poland Romania

  • Study on Switching to Insulin Glargine 300 U/ml from Insulin Glargine 100 U/ml for Patients with Type 2 Diabetes and Kidney Problems

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    Spain

  • Long-Term Study on Oxytocin for Children with Prader-Willi Syndrome Up to Age 4

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Prader-Willi syndrome
    Investigated Drugs:
    • Oxytocin
    France

  • Title: Safety and effectiveness study of pegzilarginase weekly injections in children under 2 years old with Arginase 1 Deficiency

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Arginase deficiency
    Investigated Drugs:
    • PEGZILARGINASE
    Austria Portugal
Previous Page
1 … 38 39 40 41 42 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!